Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
qishen yiqi drop pill
- Development stage
- Unknown
- Lead developer
- Tasly Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Qishen Yiqi Drop Pill (QSYQ) is a Traditional Chinese Medicine (TCM) compound widely used in China for the treatment of cardiovascular diseases. It is composed of extracts from *Astragalus membranaceus* (Huangqi), *Salvia miltiorrhiza* (Danshen), *Panax notoginseng* (Sanqi), and *Dalbergia odorifera* (Jiangxiang). The drug is primarily indicated for coronary heart disease, stable angina pectoris, and chronic heart failure. Its mechanism of action involves improving vascular endothelial function, enhancing myocardial energy metabolism, reducing inflammation, and inhibiting platelet aggregation. It is often used as an adjunctive therapy to standard Western medicine and is manufactured by Tasly Pharmaceutical Group.
- Brand names
- Qishen Yiqi Drop Pill
- Other names
- Qishen Yiqi dripping pillsQishen Yiqi dropping pills
02
Targets
ET-1 (Endothelin-1)NOS3 (eNOS)IL-6 (Interleukin 6)
Beyond the preview
Go deeper on qishen yiqi drop pill.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on qishen yiqi drop pill.